Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 15, 2014 - Issue 11
Submit an article Journal homepage
357
Views
6
CrossRef citations to date
0
Altmetric
Original Research

In vitro effect of IL-2 in combination with pazopanib or sunitinib on lymphocytes function and apoptosis of RCC cells

Alaaeldin ShablakSaint James University Hospital, Leeds, West Yorkshire, UK;University of Manchester, Manchester, [email protected], [email protected]
,
David E GilhamUniversity of Manchester, Manchester, [email protected], [email protected]
,
Robert E HawkinsUniversity of Manchester, Manchester, [email protected], [email protected]
&
Eyad ElkordUniversity of Manchester, Manchester, [email protected], [email protected];United Arab Emirates University, Al Ain, UAE;University of Salford, Manchester, UK
Pages 1489-1499 | Published online: 03 Jun 2014

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Nizar Tannir, Hans Hammers & Asim Amin. (2018) First-line vascular endothelial growth factor targeted therapy in renal cell carcinoma: priming the tumor microenvironment for immunotherapy. Current Medical Research and Opinion 34:5, pages 825-831.
Read now
Pascaline Boudou-Rouquette, Camille Tlemsani, Benoit Blanchet, Olivier Huillard, Anne Jouinot, Jennifer Arrondeau, Audrey Thomas-Schoemann, Michel Vidal, Jérôme Alexandre & François Goldwasser. (2016) Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review. Expert Opinion on Drug Metabolism & Toxicology 12:12, pages 1433-1444.
Read now

Articles from other publishers (4)

Miki Watanabe, Kozo Nakai, Yoshiko Iwaki, Toshiyuki Ozawa, Riei Kamo & Daisuke Tsuruta. (2020) Successful long‐term treatment with pazopanib after prior interleukin‐2 therapy in patients with metastatic cutaneous angiosarcoma of the scalp. Dermatologic Therapy 33:6.
Crossref
Sergio Bracarda, Camillo Porta, Roberto Sabbatini & Licia Rivoltini. (2019) Angiogenic and immunological pathways in metastatic renal cell carcinoma: A counteracting paradigm or two faces of the same medal? The GIANUS Review. Critical Reviews in Oncology/Hematology 139, pages 149-157.
Crossref
Caglar Yildiz, Turgut Kacan, Ozlem Bozoklu Akkar, Savas Karakus, Selen Baloglu Kacan, Hatice Ozer & Ali Cetin. (2015) Effects of Pazopanib, Sunitinib, and Sorafenib, Anti-VEGF Agents, on the Growth of Experimental Endometriosis in Rats. Reproductive Sciences 22:11, pages 1445-1451.
Crossref
Eva Juengel, Dana Kim, Jasmina Makarević, Michael Reiter, Igor Tsaur, Georg Bartsch, Axel Haferkamp & Roman A. Blaheta. (2015) Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib. Journal of Cellular and Molecular Medicine 19:2, pages 430-441.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.